Lupus anticoagulant, ankylosing spondylitis, and thrombosis
Ames, P.R.; Lubrano, E.; Scarpa, R.; Iannaccone, L.; Brancaccio, V.
Journal of Rheumatology 20(9): 1626-1628
1993
ISSN/ISBN: 0315-162X PMID: 8164231 Document Number: 411009
Document emailed within 1 workday
Related Documents
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76Good, A.E.; Cassidy, J.T.; Mutchnick, M.G.; Reed, R.E.; Lederman, H.M. 1977: Ankylosing spondylitis with selective IgA deficiency and a circulating anticoagulant Journal of Rheumatology 4(3): 297-302
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Asherson, R.A.; Lanham, J.G.; Hull, R.G.; Boey, M.L.; Gharavi, A.E.; Hughes, G.R. 1984: Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant" Clinical and Experimental Rheumatology 2(1): 75-79
Nashel, D.J.; Leonard, A.; Mann, D.L.; Guccion, J.G.; Katz, A.L.; Sliwinski, A.J. 1982: Ankylosing spondylitis and systemic lupus erythematosus: a rare HLA combination Archives of Internal Medicine 142(6): 1227-1228
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Gschwandtner, M.E.; Eichinger, S.; Hütter, D.; Korninger, L.; Lechner, K.; Panzer, S.; Pabinger, I. 1996: Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 7(3): 325-330
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
D'Angelo, A.; Safa, O.; Crippa, L.; Garlando, A.; Sabbadini, M.G.; Vigano' D'Angelo, S. 1997: Relationship of lupus anticoagulant, anticardiolipin, anti-beta2-GPi and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome Thrombosis and Haemostasis 78(2): 967-968
Raleigh-Rosendo, R.; Diez-Ewald, M.; Vizcaíno, G.; Fereira, H.; Arteaga-Vizcaíno, M.; Arreaza, M. 1990: Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities Investigacion Clinica 31(1): 45-55
Engelsen, J.; Nielsen, S.M.; Thorsen, S. 2006: Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome Ugeskrift for Laeger 168(5): 486-487
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Destée, A.; Devos, P.; Prin, L.; Warot, M.; Warot, P. 1985: Brain stem infarction, systemic lupus erythematosus and circulating lupus anticoagulant Revue Neurologique (Paris) 141(3): 236-239
Wysocka, K.; Kiczak, J.; Pozorska, D. 1977: Immunocoagulopathy (lupus anticoagulant) with severe hemorrhagic diathesis in systemic lupus erythematosus Wiadomosci Lekarskie 30(14): 1129-1134
Hatron, P.Y.; Bouchez, B.; Wattel, A.; Arnott, G.; Devulder, B. 1986: Chorea, systemic lupus erythematosus, circulating lupus anticoagulant Journal of Rheumatology 13(5): 991-993
Jajić, Z. 2000: Ankylosing spondylitis Reumatizam 47(2): 18-19